Basics Amneal Pharmaceuticals, Inc. IPO Date: January 1, 1900 Sector: Healthcare Industry: Biotech Market Cap: $2.59B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.51% Avg Daily Range (30 D): $0.11 | 1.37% Avg Daily Range (90 D): $0.13 | 1.70% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): 1.19M Avg Daily Volume (90 D): 1.42M Trade Size Avg Trade Size (Sh.): 152 Avg Trade Size (Sh.) (30 D): 95 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 1,676 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $2.34M Avg Inst. Trade (90 D): $2.21M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.67M Avg Closing Trade (30 D): $2.72M Avg Closing Trade (90 D): $2.49M Avg Closing Volume: 203.33K     News Jul 18, 2025 @ 11:00 AM Knight Therapeutics Announces Filing of New Drug S... Source: Knight Therapeutics Inc. Jul 18, 2025 @ 11:00 AM Thérapeutique Knight annonce le dépôt dâ... Source: Samira Sakhia Jun 25, 2025 @ 12:00 PM Amneal Highlights Positive Topline Results from Co... Source: N/A Jun 12, 2025 @ 12:00 PM Amneal Receives U.S. FDA Approval for Prednisolone... Source: Amneal Pharmaceuticals, Inc. Jun 9, 2025 @ 8:56 AM Selective Estrogen Receptor Modulators Market Rese... Source: Researchandmarkets.Com Financials   TTM Q4 2024 FY 2024 Basic EPS $.04 $-.1 $-.38 Diluted EPS $.04 $-.1 $-.38 Revenue $ 695.42M $ 730.52M $ 2.79B Gross Profit $ 255.89M $ 262.87M $ 1.02B Net Income / Loss $ 24.62M $ -20.74M $ -73.88M Operating Income / Loss $ 100.35M $ 75.79M $ 249.33M Cost of Revenue $ 439.53M $ 467.65M $ 1.77B Net Cash Flow $ -50.03M $ 40.08M $ 19.31M PE Ratio 0.00     Splits Aug 26, 2013:   1:25